Patrick J. Christmas serves as the Executive Vice President, Chief Strategy and Legal Officer at REGENXBIO Inc., a leading clinical-stage biotechnology company focused on the development and commercialization of gene therapies. In his role, Christmas is responsible for overseeing the company's strategic initiatives, legal affairs, and intellectual property management. His leadership is instrumental in navigating the complex regulatory landscape of gene therapy and ensuring that REGENXBIO remains at the forefront of innovation in the field. Before joining REGENXBIO, Christmas had an extensive career in the life sciences industry, with a strong background in both legal and strategic roles. He previously served as the Senior Vice President and General Counsel at Spark Therapeutics, where he played a key role in the company's successful development and commercialization of the first FDA-approved gene therapy for a genetic disease. His experience also includes time at GlaxoSmithKline, where he held various positions in the legal department, focusing on intellectual property and commercial transactions. Christmas's deep understanding of the biotech industry, combined with his legal expertise, has been crucial in driving REGENXBIO's growth and success. Christmas holds a Juris Doctor degree from the University of Pennsylvania Law School and a Bachelor of Arts in Biology from the University of Pennsylvania. His educational background in both law and science has uniquely positioned him to contribute to REGENXBIO's mission of transforming the lives of patients suffering from severe diseases. Under his guidance, the company continues to advance its pipeline of innovative gene therapies, with the goal of bringing life-changing treatments to market.